AstraZeneca Bounds Higher On Fourth-Quarter Beat, Upbeat Guidance

cafead

Administrator
Staff member
  • cafead   Feb 06, 2025 at 12:02: PM
via AstraZeneca (AZN) stock surged early Thursday after the pharma company reported core earnings of $2.09 per share on $14.89 billion in fourth-quarter sales.

article source